Evaluation of the Efficacy and the Cutaneous Acceptability of a Dermocosmetic Product in the Repigmentation of Vitiligo

•Inclusion Criteria: Sexe: female and male;

* Age: over 18 years old;
* Patients with stable non-segmental vitiligo lesions (defined as no new lesions or lesions that have been present for at least 3 months, lack of hypochromic margins in Wood's lumen and absence of confetti depigmentation);
* Patients with 2 to 6 symmetrical lesions (1 to 3 on each side). These lesions (macules) will be treated for a minimum surface of 2 cm² and a maximum surface of 100 cm².
* Healthy volunteer;
* Volunteer having given in writing his free, informed and express consent;
* Volunteer willing to abide by the protocol and procedures of the study.

Exclusion Criteria:

* Pregnant woman or woman who is breastfeeding or planning for early pregnancy during the study;
* Patient with segmental or mixed vitiligo;
* Patient with vitiligo of the external genitalia;
* Patient with vitiligo touching hands and feet only
* Patient with a history of skin cancer or pre-cancerous skin lesions;
* Patient taking topical or systemic vitiligo treatments in the month prior to the start of the study;
* Patient taking concomitant local or general corticosteroid therapy or immunomodulatory therapy;
* Patient with a history of photodermatoses or taking photosensitizing medications;
* Patient having planned to expose himself (artificial sun or UV) during the study at the level of the zones to be treated and / or having been exposed during the month preceding the beginning of the study and having an acquired pigmentation (tanning) obvious;
* Patient who had been treated with phototherapy within 4 weeks before randomization;
* Patient with lithium allergy.